JPRN-UMIN000008164已完成4 期
Restart for sustaining remission of rheumatoid arthritis in use of etanercept - RESUME
Osaka City University Medical School0 个研究点目标入组 31 人开始时间: 2012年6月13日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 31
研究概览
简要总结
All 13 patients achieved LDA at final follow-up. Although joint damage progressed in patients using ETN on-demand, structural damage progression in the on-demand group was not significantly different from that in controls. On-demand use of ETN for flaring reduced disease activity but not structural damage in 50% of patients (though not significantly). However, inhibition of joint damage was achieved in 50% of patients after 2 years.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The patients with severe joint destruction of hands and feet because the evaluation of Sharp score will be impossible 2.The patients who take tacrolimus 3.The patients receiving glucocorticoid over 5mg/day
研究者
相似试验
终止
3 期
Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)Rheumatoid ArthritisNCT00521924Merck Sharp & Dohme LLC8
已完成
不适用
Research into the effects of lower doses rituximab in patients with rheumatoid arthritisRheumatoid ArthritisNL-OMON23732The Sint Maartenskliniek140
已完成
2 期
Phase 2 AMG 714 in Rheumatoid ArthritisRheumatoid ArthritisNCT00433875Amgen180
已完成
1 期
BTT-1023 in Rheumatoid ArthritisRheumatoid ArthritisNCT00851240Biotie Therapies Corp.24
已完成
4 期
Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid ArthritisActive Rheumatoid ArthritisArthritis, RheumatoidRheumatoid ArthritisNCT00913458Pfizer306